Toronto Research Chemicals has Been Acquired by LGC

August 12, 2019

Toronto Research Chemicals (“TRC” or “the Company”), a leading manufacturer and supplier of synthetic organic bio-chemicals which are used as reference standards, research tools and building blocks by a highly diversified global customer base across the pharmaceutical, applied and research sectors, has been acquired by LGC, a portfolio company of KKR.

Cain Brothers, a division of KeyBanc Capital Markets (“Cain Brothers”) served as TRC’s lead financial advisor in connection with the transaction.

TRC has a leading market position supported by an extensive product portfolio with over 46,000 compounds held in inventory and a wide breadth of synthetic and analytical chemistry capabilities. Founded in 1982 by David and Charles Dime, TRC has over 375 employees and operates from c.120,000 square foot of space across two manufacturing sites in Toronto.

LGC is an international leader in the extended life sciences sector. LGC provides a comprehensive range of reference materials, proficiency testing schemes, genomics reagents and instrumentation, as well as research and measurement services. LGC serves customers across various end markets.

For more information, please contact: